BioMarin to Present at the Oppenheimer Healthcare Conference
|
| Posted
:
Tue, 27 Oct 2009 20:02:33 GMT |
| Author
:
BioMarin Pharmaceutical Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
NOVATO, Calif., Oct. 27 CA-BMRN@Oppenheimer
NOVATO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company update at the Oppenheimer Healthcare Conference in New York City on Tuesday, November 3, 2009 at 1:35 p.m. ET.
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.
About BioMarin
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme速 (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme速 (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan速 (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.
BioMarin速, Naglazyme速 and Kuvan速 are registered trademarks of BioMarin Pharmaceutical Inc.
Aldurazyme速 is a registered trademark of BioMarin/Genzyme LLC.
Contacts:
Investors Media
Eugenia Shen Susan Berg
BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc.
(415) 506-6570 (415) 506-6594
SOURCE BioMarin Pharmaceutical Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
ComplyWorks Ltd. Partners With ENFORM to Deliver Online Training to the Oil & Gas Industry
CALGARY, ALBERTA -- 11/26/09 --
ComplyWorks Ltd., today announced that they have entered into a partnership agreement with ENFORM to deliver ENFORM online learning courses across their membership base.
"With companies facing increasing in..
Media Advisory/Bombardier to Hold a Conference Call: Financial Results for the Third Quarter Ended October 31, 2009
MONTREAL, QUEBEC -- 11/26/09 --
(TSX: BBD.A)(TSX: BBD.B) - Bombardier Inc.'s financial results for the third quarter ended October 31, 2009, will be released Thursday, December 3, 2009. Pierre Beaudoin, President and Chief Executive Officer, Bombar..
CN executive vice-president Claude Mongeau to address The Morgan Stanley Transportation Corporate Access Day Dec. 2
MONTREAL, Nov. 26 - Claude Mongeau, CN executive vice-president, will address The Morgan Stanley Transportation Corporate Access Day in New York on Wednesday, Dec. 2, 2009, at 12:00 p.m. Easter...
Fancamp Announces Flow-Through Financing
VANCOUVER, BRITISH COLUMBIA -- 11/26/09 --
Fancamp Exploration Ltd. (TSX VENTURE: FNC) Fancamp Exploration Ltd. (the "Company") wishes to announce a new financing of $450,000 through the sale of 900,000 flow-through units (the "FT Units") at $0.50 ..
Mitsubishi Motors Corporation and Mitsubishi Corporation Deliver 4 i-MiEV Electric Vehicles to the Principality of Monaco
Tokyo, Nov 26, 2009 - (JCN Newswire) - Mitsubishi Motors Corporation (MMC) and Mitsubishi Corporation (MC) jointly delivered 4 units of the new-generation electric vehicle (EV) i-MiEV to the Principality of Monaco on November 25th. A number of related parties including H...
Applications Open for Toyota Choreography Award 2010
Tokyo, Nov 26, 2009 - (JCN Newswire) - TOYOTA MOTOR CORPORATION (TMC) announces it will begin accepting applications today for the Toyota Choreography Award 2010. The award program, conducted in collaboration with the Setagaya Public Theatre, is part of TMC's socia...
Mazda3 Receives Maximum Five Star Euro NCAP Safety Rating
Hiroshima, Nov 26, 2009 - (JCN Newswire) - The Mazda3 (known as the Mazda Axela in Japan) with European specifications has been awarded the maximum five-star rating by the European New Car Assessment Programme(1)(Euro NCAP) in its 2009 combined safety performance test.
|
|
|
|
|
|
|
|
|
